tert-Butyl 5-(hydroxymethyl)-1H-benzo[d]imidazole-1-carboxylate, 95+%, 100mg

n'-(2-Chloroacetyl)-4-fluorobenzohydrazide, 95%, 250mg

CEFTIZOXIME, 95%, 5g

(1R,4aR,4bR,10aR)-Ethyl 7-isopropyl-1,4a-dimethyl-1,2,3,4,4a,4b,5,6,10,10a-decahydrophenanthrene-1-carboxylate, 25g

4-Chlorobenzeneboronic acid, 98.0%, 10g

((2S,3S)-2-methylmorpholin-3-yl)methanol hydrochloride, 98%, 100mg

2-[3-[Bis(1-methylethyl)amino]-1-phenylpropyl]-4-(methoxymethyl)phenol, 96%, 100mg

(S)-N-((3-(3-Fluoro-4-(4-(2-hydroxyacetyl)piperazin-1-yl)phenyl)-2-oxooxazolidin-5-yl)methyl)acetamide, 95.00%, 25mg

N-(3-Amino-4-chlorophenyl)acetamide, 95.0%, 25g

(S)-4-(4-HYDROXY-PHENYL)-5-OXO-OXAZOLIDINE-3-CARBOXYLIC ACID TERT-BUTYL ESTER, 95.0%, 500mg

(2-{[(tert-butoxycarbonyl)amino]methyl}-1H-benzimidazol-1-yl)acetic acid, 95.0%, 1g

Ethyl 3-(2,5-dichlorophenyl)-3-oxopropanoate, 95.0%, 1g

1-Methyl-4-(prop-2-yn-1-yl)piperazine, 98%, 500mg